Immunotherapy for Type 1 Diabetes – Preclinical and Clinical Trials | IntechOpen
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
Immunotherapy in Autoimmune Type 1 Diabetes | The Review of Diabetic Studies
A Step Toward Diabetes Immunotherapy | Harvard Medical School
Approaches in the Treatment of Type 1 Diabetes Mellitus | EMJ Reviews
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Immunotherapy for type 1 diabetes: what's in the pipeline? - The Pharmaceutical Journal
The challenge of modulating β-cell autoimmunity in type 1 diabetes - The Lancet Diabetes & Endocrinology
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Collaborative Focused On Immunotherapy In Type 1 Diabetes – ANZ First | ATIC
Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes - ScienceDirect
Antigen-specific therapy against Type 1 diabetes: mechanisms and perspectives | Immunotherapy
New immunotherapy trials could help people with type 1 diabetes - Diabetes Australia
Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes - ScienceDirect
Immunotherapy: Building a bridge to a cure for type 1 diabetes | Science
Retraining the immune system to fight type 1 diabetes | Diabetes UK
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology
Immunotherapy in type 1 diabetes - Media Centre | EASD
DNA Immunotherapies for Type 1 Diabetes | IntechOpen
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
Imcyse's Type 1 Diabetes Immunotherapy Shows Promise in Phase I
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
The rise, fall, and resurgence of immunotherapy in type 1 diabetes - ScienceDirect